L. Sahlman et al., PROTECTIVE EFFECTS OF HALOTHANE BUT NOT ISOFLURANE AGAINST GLOBAL ISCHEMIC-INJURY IN THE ISOLATED WORKING RAT-HEART, Acta anaesthesiologica Scandinavica, 39(3), 1995, pp. 312-316
The effects of equi-anaesthetic concentrations of halothane (HAL) and
isoflurane (ISO) on myocardial performance, perfusion, oxygenation and
lactate release were studied before, during and after a low-flow, glo
bal ischaemic insult in isolated, paced rat left heart preparations. A
n antegrade perfusion technique was used, where left atrial pressure (
LAP) and mean aortic pressure (MAP) could be altered independently of
each other. Aortic flow, coronary flow (CF) and PO2 in venous coronary
effluent were continuously recorded and stroke volume, myocardial oxy
gen consumption (MVO(2)) and myocardial oxygen extraction as well as l
actate release were calculated. The hearts were exposed for at least t
en minutes to the perfusate without (control, n=10) or with HAL (n=10)
or ISO (n=10) at a MAP of 80 mmHg (10.4 kPa) and a LAP of 7.5 mmHg (1
.0 kPa). After baseline measurements, MAP was reduced to 25 mmHg (3,2
kPa) for a total of nine minutes. Thereafter MAP was increased to 80 m
mHg (10.4 kPa) for another nine minute period. During the whole experi
mental procedure, LAP was maintained at 7.5 mmHg (1.0 kPa) and heart r
ate at 325 beats per minute. In the pre-ischaemic control period, MVO(
2) was lower with HAL, compared to ISO (P<0.05) and control (P<0.05).
Stroke volume was also lower with HAL compared to control (P<0.05). Du
ring hypoperfusion, lactate release was twice as high in the control g
roup (P<0.01) and with ISO (P<0.01) compared to HAL. This was accompan
ied by a lower oxygen extraction with HAL compared to control (P<0.05)
and ISO (P<0.05). Tn the post-ischaemic periods, MVO(2) and stroke vo
lume were lower with HAL compared to ISO and control. There were no si
gnificant differences in CF between the groups. We conclude that HAL,
but not ISO, exerts a direct protective effect against a glycotic anae
robic metabolism during low-flow global myocardial ischaemia.